Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts
Class II · Moderate risk Terminated Initiated Aug 3, 2018 (8 years ago)

dr. brandt

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

Failed Stability Specifications: separation of product and failure for actives.

Cause type: Stability / shelf life

The product degraded or failed stability testing before its labeled expiry. Heat, moisture or time can break the drug down into degradants or reduce potency. All stability / shelf life recalls.

What was recalled

dr. brandt, BB cream with signature FLEXITONE, SPF 30, 1 oz./30 g tube, Distributed by: Cosmetic Dermatology, Inc., Miami, FL 33172, UPC 6 63963 00828 7.

Recalling firm
Product Quest Manufacturing LLC
Origin
FL, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0065-2019 · FDA notice

Check, then ask. Class II means harm is possible but usually temporary or reversible. Find the lot number on your package; if it matches, ask your pharmacist about a replacement. Do not simply stop a prescribed medication on your own - the gap can be riskier than the recall. This recall is now terminated, which means the firm has finished removing the affected product; anything on pharmacy shelves today should be unaffected.

Other recalls by Product Quest Manufacturing LLC

All 2018 recalls
Class II · Moderate risk

Finafta Baby

CGMP Deviations: products manufactured under conditions that could impact its product quality.

Terminated cGMP deviation Product Quest Manufacturing LLC D-0079-2019
Class II · Moderate risk

Rexall

CGMP Deviations: products manufactured under conditions that could impact its product quality.

Terminated cGMP deviation Product Quest Manufacturing LLC D-0078-2019
Class II · Moderate risk

Rexall

CGMP Deviations: products manufactured under conditions that could impact its product quality.

Terminated cGMP deviation Product Quest Manufacturing LLC D-0077-2019

Other stability / shelf life recalls from 2018

All stability / shelf life recalls
Class III · Low risk

Megestrol Acetate Oral Suspension

Failed Stability Specifications: Out-of-Specification results obtained for particle size distribution during stability testing.

Terminated Stability / shelf life Breckenridge Pharmaceutical, Inc. D-0279-2019
Class II · Moderate risk

Nystatin and Triamcinolone Acetonide Cream

Failed stability specifications - An out of specification result was observed for the test parameter : composition of Nystatin during stability testing.

Terminated Stability / shelf life Dr. Reddy's Laboratories, Inc. NDC 43598-431-44 D-0007-2019